Fenbufen
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| gamma-Oxo-(1,1'-biphenyl)-4-butanoic Acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | POM |
| Routes | Oral |
| Identifiers | |
| CAS number | 36330-85-5 |
| ATC code | M01AE05 |
| PubChem | CID 3335 |
| ChemSpider | 3218 |
| UNII | 9815R1WR9B |
| KEGG | D01344 |
| ChEBI | CHEBI:31599 |
| ChEMBL | CHEMBL277522 |
| Chemical data | |
| Formula | C16H14O3 |
| Mol. mass | 254.2854 |
| SMILES | eMolecules & PubChem |
|
|
| |
Fenbufen is a non-steroidal anti-inflammatory drug used primarily to treat inflammation in osteoarthritis, ankylosing spondylitis, and tendinitis. It can also be used to relieve backaches, sprains, and fractures. Fenbufen is available as a capsule or tablet sold with the brand names Cepal, Cinopal, Cybufen, Lederfen, and Reugast. Fenbufen acts by preventing cyclooxygenase from producing the prostaglandins that cause inflammation.
|
| This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |

